Search Results - "Decloedt, Eric"

Refine Results
  1. 1

    Neuronal toxicity of efavirenz: a systematic review by Decloedt, Eric H, Maartens, Gary

    Published in Expert opinion on drug safety (01-11-2013)
    “…Efavirenz commonly causes early neuropsychiatric side effects, but tolerance develops in most patients. There is emerging evidence that efavirenz use may…”
    Get more information
    Journal Article
  2. 2

    Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis by Abulfathi, Ahmed Aliyu, Decloedt, Eric H., Svensson, Elin M., Diacon, Andreas H., Donald, Peter, Reuter, Helmuth

    Published in Clinical pharmacokinetics (01-09-2019)
    “…The introduction of rifampicin (rifampin) into tuberculosis (TB) treatment five decades ago was critical for shortening the treatment duration for patients…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations by Decloedt, Eric H., Rosenkranz, Bernd, Maartens, Gary, Joska, John

    Published in Clinical pharmacokinetics (01-06-2015)
    “…The prevalence of HIV-associated neurocognitive disorder (HAND) is increasing despite the widespread use of combination antiretroviral therapy (ART). Initial…”
    Get full text
    Journal Article
  5. 5

    How COVID-19 has fundamentally changed clinical research in global health by Park, Jay J H, Mogg, Robin, Smith, Gerald E, Nakimuli-Mpungu, Etheldreda, Jehan, Fyezah, Rayner, Craig R, Condo, Jeanine, Decloedt, Eric H, Nachega, Jean B, Reis, Gilmar, Mills, Edward J

    Published in The Lancet global health (01-05-2021)
    “…COVID-19 has had negative repercussions on the entire global population. Despite there being a common goal that should have unified resources and efforts,…”
    Get full text
    Journal Article
  6. 6

    The Ocular Penetration and Intraocular Pressure Lowering Effect of Topical Acetaminophen in the New Zealand White Rabbit by Anderson, Sean G, Meyer, David, Decloedt, Eric H

    “…Emerging data suggest that acetaminophen lowers intraocular pressure (IOP) and has the potential to be repurposed as pharmacotherapy to treat open-angle…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Clozapine-Associated Leukopenia and Agranulocytosis in Western Cape, South Africa: A 3-Year Retrospective Cohort Study by Geldenhuys, Christoff, Zunza, Moleen, Tiffin, Nicki, Koen, Liezl, Decloedt, Eric H.

    Published in Journal of clinical psychopharmacology (01-05-2021)
    “…Clozapine may cause life-threatening hematological side effects (HSEs). Hematological side effect incidence data from Sub-Saharan Africa are lacking…”
    Get full text
    Journal Article
  9. 9

    Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV) by Bekker, Adrie, Decloedt, Eric H, Slade, Gretchen, Cotton, Mark F, Rabie, Helena, Cressey, Tim R

    Published in Clinical infectious diseases (01-06-2021)
    “…Abstract Abacavir is a potential option for prophylaxis and early treatment of human immunodeficiency virus (HIV), but no data are available in neonates. Ten…”
    Get full text
    Journal Article
  10. 10

    The 12-month period prevalence and cardiac manifestations of HIV in patients with acute coronary syndrome at a tertiary hospital in Cape Town, South Africa: a retrospective cross-sectional study by Pennefather, Camilla, Esterhuizen, Tonya, Doubell, Anton, Decloedt, Eric H

    Published in BMC infectious diseases (07-07-2021)
    “…Abstract Background HIV-positive patients are increasingly being affected by non-communicable diseases such as coronary artery disease (CAD). Data from…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Prevalence and Characteristics of HIV-Associated Stroke in a Tertiary Hospital Setting in South Africa by Corbett, Craig, Brey, Naeem, Pitcher, Richard D., O'Hagan, Suzanne, Esterhuizen, Tonya M., Chow, Felicia C., Decloedt, Eric H.

    Published in Neurology (30-08-2022)
    “…BACKGROUND AND OBJECTIVESAntiretroviral treatment (ART) era HIV-associated stroke data from sub-Saharan Africa are limited. We determined the prevalence of HIV…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS) by van Rensburg, Roland, Nightingale, Sam, Brey, Naeem, Albertyn, Christine H, Kellermann, Tracy A, Taljaard, Jantjie J, Esterhuizen, Tonya M, Sinxadi, Phumla Z, Decloedt, Eric H

    Published in Clinical infectious diseases (31-08-2022)
    “…Abstract Background The late-onset efavirenz neurotoxicity syndrome (LENS) presents as ataxia and/or encephalopathy with supratherapeutic efavirenz plasma…”
    Get full text
    Journal Article
  15. 15

    A Retrospective Study Evaluating Neonatal Vancomycin Loading Doses to Achieve a Therapeutic Target by Fataar, Aaqilah, Pillay-Fuentes Lorente, Veshni, Decloedt, Eric H, van Eck, Andrew, Reddy, Kessendri, Dramowski, Angela, Bekker, Adrie

    Published in Therapeutic drug monitoring (11-06-2024)
    “…Vancomycin is a glycopeptide antibiotic that has been used to treat hospital-acquired gram-positive infections for more than 5 decades. However, the literature…”
    Get full text
    Journal Article
  16. 16

    Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations by Abulfathi, Ahmed A., Chirehwa, Maxwell, Rosenkranz, Bernd, Decloedt, Eric H.

    Published in Journal of clinical pharmacology (01-09-2018)
    “…The glycopeptide antibiotic vancomycin is used for treatment of methicillin‐resistant Gram‐positive cocci. Adequate vancomycin plasma concentrations are…”
    Get full text
    Journal Article
  17. 17

    Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018 by du Toit, Tessa, Esterhuizen, Tonya M, Tiffin, Nicki, Abulfathi, Ahmed A, Reuter, Helmuth, Decloedt, Eric H

    Published in BMC infectious diseases (30-11-2020)
    “…South Africa has one of the highest tuberculosis incidence rates. Biologic disease-modifying anti-rheumatic drugs are associated with an increased risk of…”
    Get full text
    Journal Article
  18. 18

    Concentrations of Efavirenz, Tenofovir, and Emtricitabine in Obesity: A Cross-Sectional Study by Solanke, Toyosi, Kamau, Festus, Esterhuizen, Tonya, Maartens, Gary, Khoo, Saye, Joska, John A., Kellermann, Tracy, Strijdom, Hans, Decloedt, Eric H.

    “…Background: Obesity is increasing worldwide including in people living with HIV (PLWH). Antiretroviral pharmacokinetic data in obesity are limited. Objectives:…”
    Get full text
    Journal Article
  19. 19

    The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy by Decloedt, Eric H, Maartens, Gary, Smith, Peter, Merry, Concepta, Bango, Funeka, McIlleron, Helen

    Published in PloS one (07-03-2012)
    “…Rifampicin co-administration dramatically reduces plasma lopinavir concentrations. Studies in healthy volunteers and HIV-infected patients showed that doubling…”
    Get full text
    Journal Article
  20. 20

    A preliminary review of warfarin toxicity in a tertiary hospital in Cape Town, South Africa by Decloedt, Eric H., Jacobs, Annemarie, Bassa, Fatima

    Published in Cardiovascular Journal of Africa (01-11-2017)
    “…Aim: Warfarin is a widely used anticoagulant for the prevention and treatment of thromboembolism. We conducted a retrospective review to determine the causes…”
    Get full text
    Journal Article